gene recently was identifi ed in an experimental cross between 2 chicken lines divergently selected on growth rate and found to be associated with variations in the yellow color of the breast meat. In this study, the effects of the polymorphism on several aspects of carotenoid metabolism were evaluated in chickens sharing the same genetic background except for their genotype at the BCMO1 locus. We confi rmed that BCMO1 mRNA abundance varied (P < 0.001) between the 2 homozygous genotypes (GG << AA) and in the pectoralis major muscle. By contrast, BCMO1 mRNA expression was not affected (P > 0.05) by the polymorphism in the duodenum, liver, or sartorius muscle. The breast meat of GG chickens was more (P < 0.001) yellow and richer in lutein (P < 0.01) and zeaxanthin (P < 0.05) compared to that of AA chickens whereas these variables did not differ (P > 0.05) in the other tissues tested. The GG were also characterized by reduced (P < 0.01) plasma lutein and zeaxanthin concentrations than AA without affecting plasma and tissue content of fat-soluble vitamins A and E. As lutein and zeaxanthin are usually not considered as substrates of the BCMO1 enzyme, the impact of BCMO1 polymorphism on the activity of other genes involved in carotenoid transport (SCARB1 and CD36 encoding the scavenger receptor class B type I and the cluster determinant 36, respectively) and metabolism (BCDO2 encoding β,β-carotene 9′,10′-dioxygenase 2) was evaluated. The BCMO1 polymorphism did not affect mRNA abundance of BCDO2, SCARB1, or CD36, regardless of tissue considered. Taken together, these results indicated that a genetic variant of BCMO1 specifi cally changes lutein and zeaxanthin content in the chicken plasma and breast muscle without impairing vitamin A and E metabolism.
INTRODUCTION
Carotenoids represent a wide group of naturally occurring pigments that are synthesized de novo by photosynthesizing plants, algae, and several microorganisms. Because animals do not synthesize carotenoids, they must obtain them from their diet. Among the proteins involved in carotenoid metabolism, β,β-carotene 15,15′-monooxygenase 1 (BCMO1) is mainly responsible for the central oxidative cleavage of β-carotene into 2 retinal molecules (von Lintig and Vogt, 2004) , and variations in its activity are associated with changes in plasma and tissue β-carotene and vitamin A concentrations (Hessel et al., 2007; Lindqvist et al., 2007; Leung et al., 2009) . Two fully linked SNP, positioned within the proximal promoter of the BCMO1 gene, were recently found to be associated with differential expression of the BCMO1 gene in the muscle and with variations in breast meat lutein and zeaxanthin content and yellow color in the chicken (Le Bihan-Duval et al., 2010 . The polymorphism in the promoter of the chicken BCMO1 gene provides a unique model to further explain the role of BCMO1 in controlling carotenoid metabolism and status. Indeed, the genotyping of broiler breeders at the BCMO1 locus makes it possible to produce individuals with a homogeneous genetic background but differing in their genotype at the BCMO1 locus.
Based on the comparison of these genetic variants, the aim of the present study was to assess how BCMO1 gene activity affects carotenoid status from the site of uptake (duodenum) to the sites of transport (plasma) and accumulation (liver and skeletal muscles). Because lutein and zeaxanthin are not considered to be substrates of BCMO1, the regulation of other genes involved in carotenoid cleavage [β,β-carotene 9′,10′-dioxygenase 2 (BCDO2)] and uptake [scavenger receptor class B type I (SR-BI)], encoded by the SCARB1 gene, and cluster determinant 36 (CD36) was also studied. The impact of the polymorphism on fat-soluble vitamins A and E that share common regulation pathways with carotenoids was also evaluated with its overall impact on chicken growth, tissue yields, and coloration.
MATERIALS AND METHODS
All procedures involving animals were performed in accordance with the European Union Guidelines for animal care and under authorization 37-112 delivered to C. Berri by the French Ministry of Agriculture.
Reagents
Total RNA extraction reagent (RNA Now) was obtained from Ozyme (Saint-Quentin-en-Yvelines, France). Treatment with deoxyribonuclease was done using Ambion DNA-Free 1906 Kit obtained from Clinisciences (Montrouge, France). Moleny murine leukemia virus reverse transcriptase (Superscript II) was purchased from Invitrogen (Illkirch, France) and random primers were obtained from Promega (Charbonnières les Bains, France). Real-time PCR premix (SYBR Green I qPCR Master Mix Plus) was obtained from Eurogentec (Angers, France). All-E-β-carotene, retinol, lutein, α-tocopherol, δ-tocopherol, γ-tocopherol, tocopheryl acetate, retinyl acetate, retinyl myristate, retinyl palmitate, and retinyl stearate were purchased from Sigma (Saint-Quentin-en-Yvelines, France). Zeaxanthin, β-cryptoxanthin, echinenone, 9Z-β-carotene, and 13Z-β-carotene were purchased from Carotenature (Lupsingen, Switzerland). All solvents used were ultrapure liquid chromatography grade and were obtained from VWR (Fontenay-sous-Bois, France). Ultrapure water was prepared using a milli-Q system (Millipore, Millford, MA).
Birds and Housing
Two fully linked SNP were recently identifi ed within the proximal promoter of the chicken BCMO1 gene at positions −678 and −621 bp upstream of the start codon (Le Bihan-Duval et al., 2010 . They correspond to the substitution of 2 adenines (A/A) by 2 guanines (G/G) and defi ne 2 haplotypes (AN 57 A and GN 57 G), which have been segregated within a chicken line maintained at Institut National de la Recherche Agronomique (INRA; Nouzilly, France). Heterozygous adult breeders (AG) were selected and mated to produce homozygous (AA or GG) and heterozygous offspring. Because the 2 SNP are fully linked, the genotyping only considered the SNP positioned −621 bp upstream of the start codon. The genotype was determined by high-resolution melting (Le Bihan-Duval et al., 2011) from genomic DNA extracted according to Nadaf et al. (2007) from blood (breeders) or from 2 wing feathers removed at hatching (offspring). Three genotypes were defi ned: homozygous AA and GG and heterozygous AG. Chick sex was determined by PCR according to Clinton et al. (2001) . A total of 67 chicks differing in genotype at the BCMO1 locus were studied. The distribution of BCMO1 genotypes and sex in the experimental population was 37 females of which 12 were homozygous AA, 8 homozygous GG, and 17 heterozygous AG and 30 males of which 6 were homozygous AA, 8 homozygous GG, and 16 heterozygous AG. From hatching to 9 wk, chickens were reared in a conventional poultry house (INRA, UE1295 Pôle d'Expérimentation Avicole de Tours, F-37380 Nouzilly). They were given ad libitum access to water and feed (Table 1 ). The levels of lutein and zeaxanthin in the growth diet were 2.1 μg/kg DM and 2.7 μg/kg DM of diet, respectively, and no β-carotene was detected. However, because of the extreme sensitivity of carotene molecules to temperature, oxygen, and light, we could not exclude the possibility that feed contained small amounts of β-carotenes, which may have been degraded between the experiment and chemical analysis.
Sampling and Carcass Processing
At 9 wk of age, all chickens were weighed and slaughtered, and the carcasses were processed as described in Berri et al. (2007) . Blood samples (5 mL) were collected in heparin during bleeding and immediately chilled on ice. Blood samples were centrifuged at 3,000 × g at 4°C for 10 min, and serum was aliquoted and stored at -20°C until analyzed. Duodenum mucosa, liver, pectoralis major (P. major), and sartorius (SART) muscles were collected 15 min postmortem from 7 males and 7 females of each homozygous genotype (AA and GG) and then immediately frozen in liquid N and stored at -80°C until analysis. All carcasses were processed 1 d after slaughter. Abdominal fat and breast muscles (pectoralis minor and P. major) were removed and weighed, and their respective yields were calculated and expressed as percentages of BW at slaughter.
Color Measurements
The absorbance spectrum of the plasma was measured between wavelengths 400 and 700 nm by spectrophotometry (Tecan, Infi nite M200; Tecan France S.A.S, Lyon, France). Each absorbance spectrum was translated to make the value at 530 nm equal to 0 (Nozière et al., 2006; Calderón et al., 2007) . The color index (CI), which corresponds to the absolute value of the integral of the translated spectrum between 450 and 530 nm, was measured by calculating the trapezoid area (TA) between 450 and 530 nm as follows: CI 450 to 530nm = TA 450 to 460 + TA 460 to 470 + TA 470 to 480 + TA 480 to 490 + TA 490 to 500 + TA 500 to 510 + TA 510 to 520 + TA 520 to 530 . The values were only considered when the coeffi cient of variation among 3 repetitions was <5%.
The color of P. major muscle (internal part; n = 67), duodenum (external face; n = 14), and abdominal fat (n = 14) was measured using a Miniscan spectrocolorimeter (Hunterlab, Reston, VA) according to the CIE LAB (CIE : International Commission on Illumination) trichromatic system as lightness (L*), redness (a*), and yellowness (b*) values 15 min postmortem for the duodenum and 24 h postmortem for P. major muscle and abdominal fat.
Isolation of Total RNA and Real-Time Quantitative Reverse Transcription-PCR Analysis
Total RNA was extracted from tissues (duodenum, liver, P. major, and SART muscles) of 7 females from each homozygous haplotype (AN 57 A and GN 57 G) using a commercial kit (RNA Now) according to the manufacturer's instructions derived from the original method of Chomczynski and Sacchi (1987) . Total RNA concentrations were measured by spectrophotometer [optical density measured at 260 nm (OD) 260 nm] using a NanoDrop ND-1000 (Labtech, Palaiseau, France) and their integrity was checked by electrophoresis. The cDNA was synthesized from 5 μg of total RNA using random primers and Moloney murine leukemia virus reverse transcriptase. Real-time quantitative reverse transcription-PCR analyses were performed using the ABI PRISM 7000 System (Applied Biosystems, Courtaboeuf, France), with the following primers: for BCMO1, sense 5′-AAC AAA GAA GAG CAT CCA GAG CC-3′ and antisense 5′-GCC AAG CCA TCA AAC CAG TG-3′; for BCDO2, sense 5′-GGT TTC TTT CTG AGC CTG ACC TTG-3′ and antisense 5′-CCA GCT AGG AAT AAT GGA ATA GGA-3′; for SCARB1, sense 5′-ACC TCT TTG AAG TGC AGA ACCC-3′ and antisense 5′-ATG ACA ACG ACA CCG TCT CCT-3′; for CD36 sense 5′-TCC TGT CTG CAC CCT GTC AAA-3′ and antisense 5′-GGA CGT GCT CCA AAG TTC AAA A-3′; and for 18S, sense 5′-CCA GCT AGG AAT AAT GGA ATA GGA-3′ and antisense 5′-CCG GCC GTC CCT CTT AAT-3′. Each PCR run included a negative no-template control (H 2 O), reference samples (a pool of all cDNA), and unknown samples measured in one 96-well plate. Expression was quantifi ed in triplicate and 18S rRNA was used as the endogenous control in the comparative cycle threshold method (Pfaffl , 2001 ) for each condition. 
Quantifi cation of Carotenoids and Fat-Soluble Vitamins
All carotenoids and fat-soluble vitamins were extracted from plasma and tissues (duodenum, liver, P. major, and SART muscles) of 7 females from each homozygous haplotype (AN 57 A and GN 57 G). Extractions were performed at room temperature under yellow light to minimize light-induced damage, according to a slightly modifi ed version of the technique described by Chauveau-Duriot et al. (2010) . Briefl y, for plasma an 800-μL aliquot was deproteinized by adding 1 mL of ethanol containing echinenone, retinyl acetate, and tocopherol acetate (as internal standards). The mixture obtained was extracted twice with 2 mL of hexane. The hexane phases obtained after centrifugation (1,000 × g for 5 min at room temperature) were pooled and evaporated to dryness under N. The dried extract was dissolved in 20 μL of tetrahydrofuran and then with 180 μL of ac etonitrile:dichloromethane:methanol (75:10:15, vol/vol/ vol) and transferred into a 150-μL glass insert placed in a 2-mL screw-top glass vial for automatic sampling. Twenty microliters were used for ultrahigh performance liquid chromatography (UPLC) analysis according to Chauveau-Duriot et al. (2010) .
For the extraction of carotenoids and fat-soluble vitamins from tissues (duodenum, liver, SART, and P. major muscles), 200 mg to 1 g of tissue were homogenized with 1 mL of ethanol containing internal standards. The mixture was extracted twice with 4 mL of hexane. The hexane phases obtained were subjected to the same treatments as those for plasma. Five microliters of liver samples or 20 μL of other tissues were injected for UPLC analysis.
Analytical conditions for UPLC analysis were those recommended by Chauveau-Duriot et al. (2010) . In these conditions, the whole vitamin A forms (retinol and retinyl esters) were quantifi ed at 325 nm. The different retinyl esters were identifi ed by retention time and spectral analysis by comparison with pure (>95%) standards. Retention times were 12.32 (SE = 0.00) min for retinyl acetate, 29.24 (SE = 0.04) min for retinyl myristate, 33.76 (SE = 0.12) min for retinyl palmitate, and 41.52 (SE = 0.20) min for retinyl stearate. Quantifi cation of the compounds was performed using Empower Pro software (Waters Corporation, Milford, MA) and their corresponding concentrations were calculated using an external standard curve. The concentrations obtained were adjusted according to percentage recovery of the added internal standard.
Statistical Analyses
Data were analyzed using SAS (SAS Inst. Inc., Cary, NC). The accepted type I error was 5%. The effects of BCMO1 genotype (AA vs. GG) on mRNA abundance, carotenoids, vitamins, and color traits were assessed by 1-way ANOVA. For growth, body composition, and breast meat color variables, the effects of BCMO1 genotype (AA, AG, and GG), sex, and their possible interactions were analyzed by a 2-way ANOVA (GLM procedure) with type III sum of squares. The effects of tissue origin (duodenum, liver, P. major, and SART muscles) on mRNA abundance were evaluated by 1-way ANO-VA. Comparisons of means for each signifi cant effect were performed by Tukey's test using the least squares mean statement of the GLM procedure. Pearson correlation coeffi cients were analyzed with the CORR procedure to assess the relationship between BCMO1 mRNA abundance, carotenoid content, and color.
RESULTS

Variations in BCMO1 mRNA Abundance and Carotenoid Concentrations: Implication for Plasma and Tissue Coloration
All tissues tested expressed BCMO1. Its relative expression abundance was about 3-fold greater (P < 0.001) in the P. major muscle of AA than of GG chickens. By contrast, BCMO1 expression in duodenum, liver, and SART muscle was similar (P > 0.05) between AA and GG genotypes ( Figure 1A ).
Lutein and zeaxanthin were present in plasma, liver, and P. major and SART muscles ( Figures 1B and 1C ) but were not detected in the duodenum. The AA chickens exhibited greater (P < 0.01) circulating concentrations of lutein and zeaxanthin (+47 and +31%, respectively) than GG chickens. By contrast, the GG chickens exhibited greater lutein (+76%; P < 0.01) and zeaxanthin (+41%; P < 0.05) concentrations than AA chickens in the P. major muscle. Lutein and zeaxanthin concentrations were not altered (P > 0.05) by genotype in liver and SART muscle.
The genotype at BCMO1 affected (P < 0.001) the color of breast meat, GG chickens exhibiting a more yellow (greater b*) P. major muscle than AA and AG chickens (Table 2 ). This result is consistent with the correlations found in P. major muscle between the yellow index (b*) and the total lutein and zeaxanthin contents (R = 0.83; P < 0.001) and between the yellow index and the BCMO1 mRNA abundance (R = -0.73; P < 0.001). A strong negative correlation (R = -0.70; P < 0.001) also was found in breast muscle between the BCMO1 mRNA abundance and the total lutein and zeaxanthin contents, which was not found in the other tissues studied (data not shown). Despite a strong positive correlation (R = 0.85; P < 0.001) between the plasma color index and its total lutein and zeaxanthin contents, there was no difference (P > 0.05) in plasma color between AA and GG chickens ( Table 2 ). The colors of the duodenum and abdominal fat pad were not affected by genotype (data not shown).
Consequences of BCMO1 Polymorphism on FatSoluble Vitamin Concentrations, Growth, Body Composition, and SCARB1, CD36, and BCDO2 mRNA Abundance
The 3 genes (SCARB1, CD36, and BCDO2) were expressed in the duodenum, liver, and P. major and SART muscles, each with its tissue-specifi c pattern (Table 3 ). The mRNA abundance of SCARB1 and BCDO2 were much greater in the duodenum than in the liver and muscles. By contrast, CD36 mRNA abundance was much greater in liver and SART muscle than in the duodenum and P. major muscle. Regardless of the tissue, BCDO2, SCARB1, and CD36 mRNA abundance were similar between AA and GG genotypes (Table 3) .
Retinol (vitamin A) was detected in plasma and in all tissues tested and ranked as follows: liver > plasma > SART ≥ duodenum ≥ P. major (Table 4 ). The storage forms of vitamin A (retinyl esters) were detected only in the liver, with retinyl palmitate representing about 58%, retinyl stearate 39%, and retinyl myristate 3%. The α-tocopherol content (vitamin E) was almost 2-fold greater in the liver than in the plasma and duodenum and 5-fold greater than in P. major and SART muscles (Table 4 ). The γ-tocopherol concentration was less than that of α-tocopherol. The γ-tocopherol content was greater in the liver and plasma than in muscles and it was not detected in the duodenum. Neither of these vitamin A or vitamin E metabolites was affected by genotype (data not shown).
Body weight and carcass yields are presented in Table  5 . At 9 wk of age, there was no effect of BCMO1 genotype on BW, breast meat yield, or abdominal fatness (P > 0.05; Table 5 ). By contrast, gender affected BW and yields, with females being lighter (P < 0.001) and fattier (P < 0.05) and exhibiting greater (P < 0.001) breast meat yield than males. There was no interaction between gender and genotype effects on body or carcass traits (P > 0.05).
DISCUSSION
Our fi rst results linking BCMO1 gene activity and meat color were obtained in chickens originating from a F2 cross between 2 experimental lines divergently selected for high growth (HG) or low growth rate (Le Bihan-Duval et al., 2011) . The large variability observed in this F2 population for a number of production traits allowed for the identifi cation of several QTL in relation to metabolic traits, growth, body composition, and meat quality (Nadaf et al., 2007 (Nadaf et al., , 2009 ). The present study was designed to study the specifi c effect of the BCMO1 mutation, without interference with loci controlling the other traits. For this purpose, broiler breeders were selected within the HG line for their status at the BCMO1 locus to produce offspring with similar growth performances and sharing a common genetic background.
The present study included several tissues whereas the previous one focused on a single tissue, the P. major muscle. The liver and duodenum were chosen because of their central role in carotenoid uptake and storage. The SART muscle was chosen because of its distinctive contractile and metabolic properties. It is a mixed muscle containing slow-and fast-twitch fi bers with an oxydo-glycolytic metabolic profi le whereas the P. major muscle is a pure fast-twitch glycolytic muscle (Rémignon et al, 1994) . The comparison of homozygous AA and GG chickens indicated that the effects of the mutation were restricted to the P. major muscle (GG << AA) although the activity of the gene was the least in this tissue. Indeed, the mutation did not affect the activity of the gene in the SART muscle, duodenum, or liver. This tissue-specifi c response suggests that one or several tissue-specifi c transcription factor binding sites could be affected by the mutations in the BCMO1 promoter in the chicken.
The 2 linked SNP are actually proximal to a putative vitamin D receptor (VDR) response element (Le BihanDuval et al., 2011), but further evidence suggesting the involvement of this VDR in relaying the effects of the mutation on BCMO1 gene activity remains to be demonstrated. A number of previous reports (Bachmann et al., 2002; Chichili et al., 2005; Takitani et al., 2006) suggest that the activity of the BCMO1 enzyme is regulated at the transcription level; it was, therefore, assumed that the differences in BCMO1 mRNA abundance observed should lead to a decrease in activity of the BCMO1 enzyme in GG chickens.
As in the previous experiment (Le Bihan-Duval et al., 2011) , greater BCMO1 mRNA abundance in the P. major muscle in AA were associated with decreased abundance of lutein and zeaxanthin in this tissue and probably ex- 2 SCARB1 = scavenger receptor class B type 1; CD36 = cluster determinant 36; BCDO2 = β,β-carotene 9′,10′-dioxygenase 2.
3 NS = not signifi cant. plained the color differences. By contrast, in other tissues (SART muscle, duodenum, or liver) where no variations in BCMO1 mRNA abundance were observed, lutein and zeaxanthin contents were unchanged, and in the duodenum yellow color was not affected by genotype. All these fi ndings strengthened the hypothesis that the mutation was the actual cause of the meat color phenotypes. Chickens carrying the AA allele also exhibited greater plasma concentrations of lutein and zeaxanthin than GG, suggesting that change in BCMO1 gene activity in a single tissue (representing about 12% of BW) might impact plasma carotenoid concentrations. Given that these 2 carotenoids, which lack a nonsubstituted β-ionone ring, are not measurable substrates of the BCMO1 enzyme, it remains to be determined how a differential activity of this gene could impact on their tissue concentrations (Lindqvist and Andersson, 2002; Kim and Oh, 2009) .
One hypothesis might be that the activity of other enzymes or transporters involved in carotenoid metabolism could be changed. The BCDO2 can convert lutein and zeaxanthin into apocarotenoids (Mein et al., 2011; Lobo et al., 2012) . The scavenger receptors CD36 and SR-BI (encoded by the SCARB1 gene) are involved in β-carotene (During et al., 2005; van Bennekum et al., 2005) as well as in lutein (Reboul et al., 2005; Moussa et al., 2011) uptake by various tissues. Therefore, the expression of these 3 candidate genes was measured. Their mRNA abundance varied greatly between tissues but not between the 2 genotypes, which did not support their involvement in explaining differences in lutein and zeaxanthin accumulation between AA and GG chickens.
Although the role of BCMO1 has mainly been described in connection with β-carotene and vitamin A metabolism (Hessel et al., 2007; Lindqvist et al., 2007; Leung et al., 2009) , several human genetic variants near or in the BCMO1 gene have recently been reported to be associated with variations in circulating or tissue concentrations of carotenoids other than β-carotene, including zeaxanthin and lutein (Ferrucci et al., 2009; Borel et al., 2011) . In the study by Ferrucci et al. (2009) , a decrease in blood lycopene, zeaxanthin, and lutein corresponded to increases in β-carotene and α-carotene concentrations, probably because carotenoids antagonize the absorption, transport, and bioavailability of each other. Even though β-carotene was not at a detectable concentration in the plasma or the tissues, differences in BCMO1 activity between AA and GG chickens might affect its concentration, which may impact on zeaxanthin and lutein metabolism. The strong negative correlation observed between BCMO1 mRNA abundance and total amounts of lutein and zeaxanthin in breast muscle supports this hypothesis. Available β-carotene, if converted into vitamin A through the activity of the BCMO1 enzyme, may not contribute to concentrations of plasma or tissue retinoids, however, which mainly originate from dietary vitamin A. Indeed, our results show that the content of the different vitamin A forms (retinol or its retinyl ester storage forms in the liver) are not affected by genotype although as expected they differ among tissues. Loss of BCMO1 function following gene knock-out abolished vitamin A production from β-carotene in mice (Hessel et al., 2007) . It also changed lipid metabolism and susceptibility to diet-induced obesity, even on a vitamin A-suffi cient diet (Hessel et al., 2007) . In the study reported here, neither chicken growth rate nor carcass adiposity were affected by genotype. Because carotenoids and vitamin E share common transporters, a possible impact of the BCMO1 mutation on vitamin E metabolism was examined. No signifi cant effect of genotype on vitamin E concentrations in plasma or tissues occurred, which was consistent with the absence of a differential expression of the SCARB1 gene that encodes SR-BI and is involved in vitamin E uptake and bioavailability (Reboul et al., 2006; Rigotti, 2007) .
Taken together, our fi ndings show that a mutation in the BCMO1 promoter, which affects the activity of the gene in vitro (Le Bihan-Duval et al, 2011) , leads to tissue-specifi c differences in vivo. The abundance of BCMO1 mRNA and the storage of the nonprovitamin A carotenoids, lutein and zeaxanthin, were only changed in the P. major muscle (AA >> GG for BCMO1 mRNA and AA < GG for carotenoids, respectively). Plasma concentrations of lutein and zeaxanthin were affected in the opposite direction (AA > GG). The yellow color of P. major muscle and plasma was positively correlated with lutein and zeaxanthin concentrations. The mutation did not affect vitamin A or E status although these vitamins share common regulation pathways with carotenoids. In the conditions of the experiment, in which vitamin A was mainly supplied by the diet, the mutation did not affect growth or body composition of the chickens or the expression of various genes involved in uptake (SR-BI and CD36) and metabolism (BCDO2) of carotenoids. These results together indicated that a genetic variant of the BCMO1 gene can affect pigment content and yellow color of breast muscle in the chicken without impairing overall metabolism and growth.
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